Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptavidin is a 52-55 kDa homotetrameric protein purified from the bacterium *Streptomyces avidinii* that exhibits extraordinarily high affinity for biotin (vitamin B7 or H)[1][2]. With a dissociation constant on the order of 10^-14^ to 10^-15^ M, the streptavidin-biotin interaction represents one of the strongest non-covalent bonds known in nature[1][2]. **Structural characteristics**: The protein consists of four identical subunits, each composed of 159 amino acid residues in the full-length form, though it is commonly proteolytically processed to a "core" form of 125-139 residues[1][2]. Each monomer adopts an eight-stranded antiparallel β-barrel tertiary structure with a biotin-binding site located at one end of each barrel[1][3][4]. The tetrameric quaternary structure can be considered a dimer of functional dimers, with each subunit contributing critical residues (particularly Trp120) to the binding site of neighboring subunits[1][3][4]. **Binding mechanism**: The exceptional binding affinity originates from multiple factors including high shape complementarity between the binding pocket and biotin, an extensive hydrogen bonding network involving eight first-shell residues (Asn23, Tyr43, Ser27, Ser45, Asn49, Ser88, Thr90, and Asp128), numerous van der Waals interactions within the hydrophobic binding pocket lined with tryptophan residues, and stabilization of a flexible loop (L3/4, residues 45-52) that closes over bound biotin like a lid, contributing to extremely slow dissociation rates[1][3][4]. **Stability**: The streptavidin-biotin complex exhibits remarkable resistance to organic solvents, denaturants (such as guanidinium chloride), detergents (including SDS and Triton X-100), proteolytic enzymes, and extremes of temperature and pH[1]. The protein itself is stable over a wide pH range and requires up to 20 minutes at 100°C in 0.2% SDS to dissociate the tetrameric structure[2]. **Comparison to avidin**: While streptavidin shares identical biotin-binding properties with avidin (a related protein from egg white), it lacks the glycoprotein portion and has only 30% sequence homology with avidin[2]. Streptavidin's near-neutral isoelectric point (pI 5-6 versus 10 for avidin) results in lower non-specific binding in most biological applications[2]. **Applications**: Streptavidin is extensively used in molecular biology, bionanotechnology, diagnostics, and research applications including immunoassays, protein purification, detection systems, and biosensors, where its strong biotin-binding capability serves as a versatile molecular tool rather than as a therapeutic target[1][2].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptavidin (None).